Brief: ENDRA Life Sciences Reports Third Quarter 2022 Financial Results
14/11/2022 21:28
Nov 14 (Reuters) - ENDRA Life Sciences Inc NDRA.O :
* ENDRA LIFE SCIENCES REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* ENDRA LIFE SCIENCES INC - CASH AND CASH EQUIVALENTS WERE
$8.0
MILLION AS OF SEPTEMBER 30, 2022
* ENDRA LIFE SCIENCES INC - QTRLY NET LOSS PER SHARE – BASIC
AND
DILUTED $ 0.05
Source text for Eikon: ID:nBw73VKGha
Further company coverage: NDRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ENDRA Life Sciences
See all newsBrief: ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger
Endra Life Sciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 84 Cents A Share: Earnings Preview
Brief: ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences